Basics Immunovant, Inc. IPO Date: June 7, 2019 Sector: Healthcare Industry: Biotech Market Cap: $3.35B Activated in VL: True Average Daily Range Avg Daily Range: $0.53 | 2.77% Avg Daily Range (30 D): $0.44 | 2.66% Avg Daily Range (90 D): $0.39 | 2.40% Institutional Daily Volume Avg Daily Volume: .84M Avg Daily Volume (30 D): 1.44M Avg Daily Volume (90 D): 1.22M Trade Size Avg Trade Size (Sh.): 77 Avg Trade Size (Sh.) (30 D): 71 Avg Trade Size (Sh.) (90 D): 66 Institutional Trades Total Inst.Trades: 2,838 Avg Inst. Trade: $2.24M Avg Inst. Trade (30 D): $3.06M Avg Inst. Trade (90 D): $2.47M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.49M Avg Closing Trade (30 D): $4.9M Avg Closing Trade (90 D): $3.52M Avg Closing Volume: 158.01K     News Sep 17, 2025 @ 9:49 PM CENTURY ALUMINUM INVESTIGATION INITIATED BY FORMER... Source: Kahn Swick & Foti, Llc Sep 3, 2025 @ 10:17 PM Why Immunovant Stock Blasted Higher Today Source: Eric Volkman Sep 3, 2025 @ 4:57 PM Immunovant Unveils Durability and Treatment-Free S... Source: Immunovant, Inc. Aug 11, 2025 @ 11:27 AM Immunovant Posts 34% R&D Jump in Q1 Source: Jesterai Sep 9, 2024 @ 6:08 PM IMVT Stock Up on Upbeat Data From Graves' Disease ... Source: Zacks, Benzinga Contributor Financials   TTM Q1 2026 Q4 2025 Basic EPS $-2.84 $-.71 Diluted EPS $-2.84 $-.71 Revenue $ $ $ Gross Profit $ $ $ Net Income / Loss $ -447.3M $ -120.61M $ Operating Income / Loss $ $ $ Cost of Revenue $ $ $ Net Cash Flow $ 154.53M $ .57M $ PE Ratio